Jefferies & Company Inc. Raises Price Target For CME Group Inc. (CME)

Analyst Daniel Fannon at Jefferies & Company Inc. has released an update on CME Group Inc. (NASDAQ: CME). The company reported its first-quarter results on Thursday.

CME Group reported first-quarter GAAP EPS of $3.62. Following the first-quarter results, Jefferies & Company has raised its second-quarter EPS estimate for the company from $3.71 to $3.78. The price target for the company has been raised from $350 to $380.

Jefferies & Company Inc. has maintained its Buy rating for CME Group Inc.